Medtronic Aptus Heli-FX Thoracic EndoAnchor System Heli-FX Guide 42 mm, REF HG-18-90-42, STERILE ...
FDA Device Recall #Z-3227-2017 — Class II — September 13, 2017
Recall Summary
| Recall Number | Z-3227-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 13, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medtronic Vascular, Inc. |
| Location | Santa Rosa, CA |
| Product Type | Devices |
| Quantity | 20 units |
Product Description
Medtronic Aptus Heli-FX Thoracic EndoAnchor System Heli-FX Guide 42 mm, REF HG-18-90-42, STERILE EO, Rx Only The Heli-FX EndoAnchor System is intended to provide fixation and sealing between endovascular aortic grafts and the native artery. The Heli-FX System is indicated for use in patients who endovascular grafts have exhibited migration or endoleak, or are at risk for such complications, in whom augmented radial fixation and or sealing is required or regain or maintain adequate aneurysm exclusion.
Reason for Recall
It was determined that the deflection length indicated on the Guide catheter handle does not match the label on the box and sterile packaging for two lots.
Distribution Pattern
US Distribution to the states of : AZ, CA, FL, GA, MA, MI, MN and NH.
Lot / Code Information
UDI 00763000006679, Lot Number 0008674156 UDI 00763000006655, Lot Number 0008674157
Other Recalls from Medtronic Vascular, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1042-2022 | Class II | Medtronic IN.PACT Admiral, Paclitaxel-coated PT... | Mar 23, 2022 |
| Z-1043-2022 | Class II | Medtronic IN.PACT AV, Paclitaxel-coated PTA Bal... | Mar 23, 2022 |
| Z-0657-2022 | Class II | Endurant, Endurant II and Endurant IIs Stent Gr... | Dec 21, 2021 |
| Z-0290-2022 | Class II | Endurant Stent Graft System REF/Description: ... | Oct 15, 2021 |
| Z-0291-2022 | Class II | Endurant II Stent Graft System REF/Description:... | Oct 15, 2021 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.